Skip to main content
NVDA-0.02%AAPL+0.45%GOOGL-0.37%MSFT-0.58%AMZN-0.95%TSM+1.47%SPCX+1.85%META-0.83%AVGO+0.26%TSLA-1.07%LLY-1.55%BRK-B-0.06%MU+2.39%WMT-0.15%SKHY+3.80%JPM-1.15%AMD+1.40%V-1.14%XOM+1.45%JNJ-1.51%ASMLa-1.50%MA-1.34%ABBV-0.53%INTC+0.82%COST-0.50%CVX+1.61%0700.HK+0.94%1398.HK-1.50%CSCO+0.78%KO-1.12%PG-1.26%UNH-0.90%ORCL+0.29%BAC-0.70%1816.HK+0.44%HD-1.97%3988.HK-0.50%CAT-2.00%PM-0.66%0005.HK-1.04%HSBA.L-1.43%GE-3.83%0857.HK-0.93%0939.HK+0.51%AP2d-1.14%AMAT+0.51%NVS-0.40%1288.HK-1.94%MS-1.02%LRCX-1.11%EURCAD-1.52%EURAUD-1.50%EURJPY-1.20%USDCAD-1.14%AUDUSD+1.13%CADCHF+1.12%AUDCHF+1.10%EURNZD-1.02%USDTHB+0.91%GBPCAD-0.86%USDJPY-0.86%CHFJPY-0.84%GBPAUD-0.82%PLNJPY-0.71%EURGBP-0.68%NZDUSD+0.66%USDPLN+0.65%USDZAR+0.64%NZDCHF+0.62%GBPJPY-0.54%NZDCAD-0.49%AUDNZD+0.49%EURPLN+0.48%EURZAR+0.48%USDTRY+0.43%GBPZAR+0.43%GBPTRY+0.41%EURCHF-0.40%EURUSD-0.37%GBPNZD-0.37%CHFSGD-0.33%GBPHKD+0.32%AUDJPY+0.32%CADJPY+0.32%GBPUSD+0.31%USDSEK+0.30%CHFNOK-0.29%GBPMXN-0.28%GBPCHF+0.26%USDCNH-0.24%AUDDKK+0.24%EURCNH-0.21%NZDJPY-0.20%EURCZK+0.20%NZDSGD+0.19%AUDNOK+0.18%NOKJPY-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN+0.16%GBPSGD-0.15%AUDSGD+0.15%SGDJPY-0.14%EURSEK+0.13%USDNOK+0.11%CHFSEK-0.10%EURHKD-0.10%EURSGD-0.09%USDHKD-0.08%USDSGD+0.07%EURNOK-0.06%USDMXN+0.04%USDCHF-0.04%USDCOP-0.04%AUDCAD-0.01%EURDKK0.00%USOIL+3.37%UKOIL+2.58%XNGUSD-2.08%HG1+1.41%GAGUSD-1.40%XAGUSD-1.40%S1+0.64%XPTUSD-0.61%COFFEE+0.56%COCOA-0.32%COTTON-0.32%W1+0.26%BTCUSD+0.73%ETHUSD+20.55%USDTUSD+0.01%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.68%ZECUSDT+1.97%DOGEUSD+19.00%XMRUSDT+1.95%LINKUSD+19.73%XLMUSD+0.92%BCHUSDT+3.70%LTCUSD+13.73%UNIUSD+2.28%SUIUSD+2.57%HBARUSDT+0.14%TONUSD+30.40%TAOUSDT+1.34%AAVEUSD+0.67%DOTUSDT+2.79%ICPUSDT+2.46%WLDUSDT-3.53%ONDOUSDT+1.06%ARBUSDT+1.28%JUPUSDT+0.35%ATOMUSDT+3.69%INJUSDT+0.55%STXUSDT-0.75%TIAUSDT-1.92%FETUSDT+1.52%PYTHUSDT-0.16%SEIUSDT+0.84%IMXUSDT+0.82%GRTUSDT+1.14%OPUSDT+0.74%WIFUSDT+1.37%IOTAUSDT-0.04%AXSUSDT+1.92%POLUSDT+1.52%FARTCOINUSDT+0.95%EOSUSDT-2.12%DYDXUSDT+1.82%GALAUSDT+1.41%ORDIUSDT+2.47%RONINUSDT+0.24%NOTUSDT+3.13%NVDA-0.02%AAPL+0.45%GOOGL-0.37%MSFT-0.58%AMZN-0.95%TSM+1.47%SPCX+1.85%META-0.83%AVGO+0.26%TSLA-1.07%LLY-1.55%BRK-B-0.06%MU+2.39%WMT-0.15%SKHY+3.80%JPM-1.15%AMD+1.40%V-1.14%XOM+1.45%JNJ-1.51%ASMLa-1.50%MA-1.34%ABBV-0.53%INTC+0.82%COST-0.50%CVX+1.61%0700.HK+0.94%1398.HK-1.50%CSCO+0.78%KO-1.12%PG-1.26%UNH-0.90%ORCL+0.29%BAC-0.70%1816.HK+0.44%HD-1.97%3988.HK-0.50%CAT-2.00%PM-0.66%0005.HK-1.04%HSBA.L-1.43%GE-3.83%0857.HK-0.93%0939.HK+0.51%AP2d-1.14%AMAT+0.51%NVS-0.40%1288.HK-1.94%MS-1.02%LRCX-1.11%EURCAD-1.52%EURAUD-1.50%EURJPY-1.20%USDCAD-1.14%AUDUSD+1.13%CADCHF+1.12%AUDCHF+1.10%EURNZD-1.02%USDTHB+0.91%GBPCAD-0.86%USDJPY-0.86%CHFJPY-0.84%GBPAUD-0.82%PLNJPY-0.71%EURGBP-0.68%NZDUSD+0.66%USDPLN+0.65%USDZAR+0.64%NZDCHF+0.62%GBPJPY-0.54%NZDCAD-0.49%AUDNZD+0.49%EURPLN+0.48%EURZAR+0.48%USDTRY+0.43%GBPZAR+0.43%GBPTRY+0.41%EURCHF-0.40%EURUSD-0.37%GBPNZD-0.37%CHFSGD-0.33%GBPHKD+0.32%AUDJPY+0.32%CADJPY+0.32%GBPUSD+0.31%USDSEK+0.30%CHFNOK-0.29%GBPMXN-0.28%GBPCHF+0.26%USDCNH-0.24%AUDDKK+0.24%EURCNH-0.21%NZDJPY-0.20%EURCZK+0.20%NZDSGD+0.19%AUDNOK+0.18%NOKJPY-0.17%USDDKK+0.17%USDILS+0.16%NZDMXN+0.16%GBPSGD-0.15%AUDSGD+0.15%SGDJPY-0.14%EURSEK+0.13%USDNOK+0.11%CHFSEK-0.10%EURHKD-0.10%EURSGD-0.09%USDHKD-0.08%USDSGD+0.07%EURNOK-0.06%USDMXN+0.04%USDCHF-0.04%USDCOP-0.04%AUDCAD-0.01%EURDKK0.00%USOIL+3.37%UKOIL+2.58%XNGUSD-2.08%HG1+1.41%GAGUSD-1.40%XAGUSD-1.40%S1+0.64%XPTUSD-0.61%COFFEE+0.56%COCOA-0.32%COTTON-0.32%W1+0.26%BTCUSD+0.73%ETHUSD+20.55%USDTUSD+0.01%XRPUSD+14.70%SOLUSD+14.32%TRXUSDT+0.68%ZECUSDT+1.97%DOGEUSD+19.00%XMRUSDT+1.95%LINKUSD+19.73%XLMUSD+0.92%BCHUSDT+3.70%LTCUSD+13.73%UNIUSD+2.28%SUIUSD+2.57%HBARUSDT+0.14%TONUSD+30.40%TAOUSDT+1.34%AAVEUSD+0.67%DOTUSDT+2.79%ICPUSDT+2.46%WLDUSDT-3.53%ONDOUSDT+1.06%ARBUSDT+1.28%JUPUSDT+0.35%ATOMUSDT+3.69%INJUSDT+0.55%STXUSDT-0.75%TIAUSDT-1.92%FETUSDT+1.52%PYTHUSDT-0.16%SEIUSDT+0.84%IMXUSDT+0.82%GRTUSDT+1.14%OPUSDT+0.74%WIFUSDT+1.37%IOTAUSDT-0.04%AXSUSDT+1.92%POLUSDT+1.52%FARTCOINUSDT+0.95%EOSUSDT-2.12%DYDXUSDT+1.82%GALAUSDT+1.41%ORDIUSDT+2.47%RONINUSDT+0.24%NOTUSDT+3.13%
ML

Mesa Laboratories, Inc. (MLAB)

NASDAQ • Healthcare

$129.1
-$0.09 (-0.1%)
Market open

Last close at October 22, 2026 at 20:00 UTC

Open$129.27
Previous Close$129.1
Day Range$127.59 - $131.01
Avg. Volume (3M)105.7K
Market Cap$722.4M
P/E Ratio150.1
52 Week Range
$69.51$144.35
Next EarningsIn 13 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$60.1M100%
Gross Profitminus cost of goods$39M65%
Operating Incomeminus R&D and overhead$7M12%
Net Incomeminus taxes and the rest$2.8M5%

In plain terms: out of every $100 in revenue, Mesa Laboratories, Inc. keeps $5 as net profit.

Fundamentals & Financials

Revenue (TTM)
$249.7M
Net Income (TTM)
$4.8M
EPS (TTM)
$0.86
ROA (TTM)
1.14%
Current Ratio
2.07
Dividend Yield
0.16%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+119.3%Q1 2026$3.07
+32.1%Q2 2026$2.76
+1.9%Q3 2026$2.68
Next

Nov 5

in 13 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +1.9%

Mesa Laboratories’ adjusted EPS topped consensus even as revenue trailed expectations in the first fiscal quarter of 2027 (period ended June 30, 2026, reported August 10, 2026). Revenue rose 1.0% to about $60.1 million (up from roughly $59.5 million a year ago) and came in at $60.1 million versus the $60.9 million estimate (-1.2%, trailed). Profitability was supported by a gross margin of ~65% and an operating margin of ~12%, with gross profit of roughly $39.0 million and operating income of about $7.0 million. On the bottom line, net income fell 40.3% to around $2.8 million (down from about $4.7 million a year ago). Adjusted EPS of $2.68 topped the $2.63 estimate (+1.9%, topped). The company generated operating cash flow of about $14.7 million during the quarter and paid roughly $0.9 million in dividends. Next-period consensus calls for EPS of $1.59 on revenue of $61.6 million.

Next report — what to expect

Mesa Laboratories, Inc. (MLAB) reports on November 5, 2026. For the upcoming quarter, consensus calls for EPS of $2.29 on revenue of $62.2 million. As trailing context, revenue grew +1.0% year over year last quarter. Mesa has beaten EPS in 4 of 8 most recent quarters.

View full earnings history

About Mesa Laboratories, Inc.

Mesa Laboratories, Inc. (NASDAQ: MLAB) develops and sells medical and laboratory quality-control, diagnostics, and biopharma tools within healthcare, generating $249.1 million of revenue in FY2026. Its business spans sterilization and disinfection controls, clinical genomics, biopharmaceutical development, and calibration products used by regulated care and research customers.

Name
Mesa Laboratories, Inc.
CEO
Siddhartha C. Kadia
Website
www.mesalabs.com
Industry
Healthcare
Year Founded
1982
Employees
717

Today's Snapshot

AI-generated

MLAB closed flat at 129.10.

Trading Volume

Below 10d avg (87.5K)

70.5K

vs S&P 500 Today

Outperforming Market

+1.13%

Updated: October 23, 2026 at 12:10 UTC

Technical Indicators

5 Buy3 Neutral0 Sell
MLAB shows a constructive technical posture driven by price sitting above most short- and medium-term moving averages while longer-term averages also remain supportive, which aligns with the strong-buy classification. Momentum indicators are mildly positive and on-balance volume supports accumulation, while oscillators sit near neutral so there is no extreme overbought reading. ADX indicates a modest trend rather than a runaway move, and volatility is moderate at a few percent of price. The classic pivot sits slightly below current levels and acts as nearby support. Technical takeaway: Strong Buy — broad moving-average support with positive momentum and confirming volume.
All signals
  • EMA (5 indicators)$104.97 - $127.98
    Buy
  • RSI (14)52.32
    Neutral
  • Stochastic %K (14, 3, 3)25.27
    Neutral
  • MACD Level (12, 26)0.00
    Neutral

Peers & Related Assets

TMOThermo Fisher Scientific Inc.
$675.89-0.1%
AAgilent Technologies, Inc.
$173.89-2.2%
RVTYRevvity, Inc.
$157.36+0.5%
TECHBio-Techne Corporation
$72.62-0.0%
QGENQiagen N.V.
$50.22+0.4%
BIOBio-Rad Laboratories, Inc.
$363.5+0.8%
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.